Results from the ARTEMIS DISK global antifungal surveillance study: A 6.5-year analysis of susceptibilities of candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing

Journal of Clinical Microbiology

Volumn 43, Issue 12, 2005, Pages 5848-5859

  Pfaller, M A ^a   Diekema, D J ^a   Rinaldi, M G ^b   Barnes, R ^c   Hu, B ^d   Veselov, A V ^e   Tiraboschi, N ^f   Nagy, E ^g   Gibbs, D L ^h   Finquelievich, Jorge ⁱ   Ellis, David ^j   Frameree, Dominique ^k   Van Den Abeele, Annemarie ^l   Senterre, Jean Marc ^m   Colombo, Arnaldo ⁿ   Rennie, Robert ^o   Sanche, Steve ^p   Hu, Bijie ^d   Xu, Yingchun ^r   Zhang, Yingyuan ^s   Zhong, Nan Shan ^t   Rivas, Pilar ^u   Restrepo, Angela ^v   Bedout, Catalina ^v   Mendez, Ricardo Vega Matilde ^w   Mallatova, Nada ^x   Chmelarova, Eva ^y   Ayabaca, Julio ^z   Zurita, Jeannete ^aa   Mallie, M ^ab   Candolfi, E ^ac   Fegeler, W ^ad   Haase, A ^ae   Rodloff, G ^af   Bar, W ^ag   Czaika, V ^ah   Petrikos, George ^ai   Puskás, Erzsébet ^aj   Doczi, Ilona ^ak   Gyula, Mestyan ^al   Nikolova, Radka ^am   Banerjee, Uma ^an   Keller, Nathan ^ao   Tullio, Vivian ^ap   Schito, Gian Carlo ^aq   Fortina, Giacomo ^ar   Testore, Gian Piero ^as   D'Antonio, Domenico ^at   Scalise, Giorgio ^au   Martino, Pietro ^l   Manno, Graziana ^aq   Peng, Kee ^av   Alpuche, Celia ^aw   Noriega, Eduardo Rodriguez ^ax   Zaidi, Mussaret ^ay   Meis, Jacques F G M ^az   Lingaas, Egil ^ba   Dzierzanowska, Danuta ^bb   Pawliszyn, Waclaw ^bc   Martins, Mariada Luz ^bd   Albuquerque, Luis ^be   Rosado, Laura ^bf   Velho, Rosa ^be   Amorim, Jose ^bg   Ilina, Vera N ^bh   Kretchikova, Olga I ^e   Klyasova, Galina A ^bj   Rozanova, Sophia M ^bk   Multykh, Irina G ^bl   Klimko, Nikolay N ^bm   Agapova, Elena D ^bn   Dmitrieva, Natalya V ^bo   Al Rasheed, Abdul Mohsen ^bp   Trupl, Jan ^bq   Langsadl, Leon ^br   Vaculikova, Alena ^bs   Helena, Hupkova ^bt   Roditi, Denise ^bu   Hoosen, Anwar ^bv   Crewe Brown, H H ^bw   Janse Van Rensburg, M N ^bx   Duse, Adriano ^by   Lee, Kyungwon ^bz   Kim, Mi Na ^ca   Del Palacio, A ^cb   Sanchez Sousa, Aurora ^cc   Bille, Jacques ^cd   Muhlethaler, K ^ce   Chang, Shan Chwen ^cf   Wang, Jen Hsien ^cg   Vorachit, Malai ^ch   Gur, Deniz ^ci   Korten, Volkan ^cj   Paul, John ^ck   Jones, Brian ^cl   Gould, F Kate ^cm   Kibbler, Chris ^cn   Weightman, Nigel ^co   Gould, Ian M ^cp   Ashbee, Ruth ^cq   Barnes, Rosemarie ^c   Vazquez, Jose ^cr   Chan, Ed ^cs   Larone, Davise ^ct   Baron, Ellen Jo ^cu   Ghannoum, Mahmoud A ^cv   Rinaldi, Mike ^b   Hazen, Kevin ^cw   Foraker, Elyse ^cx   Reyes, Heidi ^bi   Santiago, Axel ^q   more..

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^e Scientific Research Institute of Antimicrobial Chemotherapy   (Russian Federation)

^f HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^g UNIVERSITY OF SZEGED   (Hungary)

^h Giles Scientific Inc   (United States)

ⁱ UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^j WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^k CHU de Jumet   (Belgium)

^l St Lucas Campus Heilige Familie ^*  (Italy)

^m Centre Hospitalier Regional de La Citadelle   (Belgium)

ⁿ FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^o UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^p ROYAL UNIVERSITY HOSPITAL   (Canada)

^q Universitario de Caracas   (Venezuela)

^r PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^s FUDAN UNIVERSITY   (China)

^t GUANGZHOU MEDICAL UNIVERSITY   (China)

^u Instituto Nacional de Cancerología   (Colombia)

^v CIB   (Colombia)

^w HOSPITAL MILITAR CENTRAL   (Colombia)

^x Hospital Ceske Budejovice   (Czech Republic)

^y Krajska Hygienicka stanice se sidlem v Ostrave   (Czech Republic)

^z Hospital FF AA HG1   (Ecuador)

^aa HOSPITAL VOZANDES   (Ecuador)

^ab UNIV MONTPELLIER   (France)

^ac Inst Parasitol et de Pathol Trop   (France)

^ad UNIVERSITY OF MÜNSTER   (Germany)

^ae RWTH AACHEN UNIVERSITY   (Germany)

^af Inst F Med Informatik Stat E   (Germany)

^ag CARL THIEM KLINIKUM   (Germany)

^ah Humaine Kliniken   (Germany)

^ai LAIKO GENERAL HOSPITAL   (Greece)

^aj Hospital of BAZ County   (Hungary)

^ak UNIVERSITY OF SZEGED   (Hungary)

^al UNIVERSITY OF PÉCS   (Hungary)

^am Szent Laszlo Hospital   (Hungary)

^an ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^ao SHEBA MEDICAL CENTER   (Israel)

^ap UNIVERSITY OF TURIN   (Italy)

^aq UNIVERSITY OF GENOA   (Italy)

^ar Ospedale Di Novara   (Italy)

^as UNIVERSITY OF ROME TOR VERGATA   (Italy)

^at Ospedale Civile di Pescara   (Italy)

^au Instituto di Malattie Infettive   (Italy)

^av UNIVERSITY OF MALAYA   (Malaysia)

^aw HOSPITAL GENERAL DE MÉXICO   (Mexico)

^ax UNIVERSITY OF GUADALAJARA   (Mexico)

^ay Hospital General O'Horan   (Mexico)

^az CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^ba OSLO UNIVERSITY HOSPITAL   (Norway)

^bb CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^bc Szpital Uniwersyteckiego   (Poland)

^bd INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^be CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^bf NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^bg HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^bh Novosibirsk State Regional Clinical Hospital   (Russian Federation)

^bi Gen del Este Domingo Luciani   (Venezuela)

^bj NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

^bk Triton ElectronicS Ltd   (Russian Federation)

^bl Territory Center of Laboratory Diagnostics   (Russian Federation)

^bm Research Institute of Mycology   (Russian Federation)

^bn Irkutsk Regional Children's Hospital   (Russian Federation)

^bo Oncological Research Center   (Russian Federation)

^bp The General Directorate of Armed Forces Health Services   (Saudi Arabia)

^bq National Cancer Center   (United States)

^br NUTaRCH   (United States)

^bs Derer 's University Hospital Slovakia   (Slovakia)

^bt St Cyril and Method's Hospital   (Slovakia)

^bu UNIVERSITY OF CAPE TOWN   (South Africa)

^bv SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^bw UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^bx UNIVERSITY OF THE FREE STATE   (South Africa)

^by UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^bz Yonsei University College of Medicine   (South Korea)

^ca Asan Medical Center   (South Korea)

^cb HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^cc HOSPITAL RAMÓN Y CAJAL   (Spain)

^cd LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^ce UNIVERSITY OF BERN   (Switzerland)

^cf NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^cg CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^ch MAHIDOL UNIVERSITY   (Thailand)

^ci HACETTEPE UNIVERSITY   (Turkey)

^cj MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^ck ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^cl GLASGOW ROYAL INFIRMARY   (United Kingdom)

^cm FREEMAN HOSPITAL   (United Kingdom)

^cn ROYAL FREE HOSPITAL   (United Kingdom)

^co FRIARAGE HOSPITAL   (United Kingdom)

^cp NHS GRAMPIAN   (United Kingdom)

^cq LEEDS GENERAL INFIRMARY   (United Kingdom)

^cr WAYNE STATE UNIVERSITY   (United States)

^cs MOUNT SINAI MEDICAL CENTER   (United States)

^ct WEILL CORNELL MEDICAL CENTER   (United States)

^cu STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^cv UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^cw UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^cx Christiana Care   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CANDIDA KRUSEI; CANDIDIASIS; DEVICE; DRUG SENSITIVITY; FUNGUS GROWTH; FUNGUS ISOLATION; IMAGE ANALYSIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; QUALITY CONTROL; STANDARDIZATION; YEAST;

CANDIDA; FUNGI; ISSATCHENKIA ORIENTALIS;

EID: 30744462355     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.12.5848-5859.2005     Document Type: Article

References (34)

1. Brandt, M. E., M. A. Pfaller, R. A. Hajjeh, R. H. Hamill, P. G. Pappas, A. L. Reingold, D. Rimland, and D. W. Warnock for the Cryptococcal Disease Active Surveillance Group. 2001. Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob. Agents Chemother. 45:3065-3069.
2. 1a. CLSI. 2005. Minutes of the CLSI Antifungal Subcommittee Meeting, 2005. CLSI, Wayne, Pa.
3. Colombo, A. L., S. A. Melo, R. F. C. Rosas, R. Salomao, M. Briones, R. J. Hollis, S. A. Messer, and M. A. Pfaller. 2003. Outbreak of Candida rugosa candidemia; an emerging pathogen that may be refractory to amphotericin B therapy. Diagn. Microbiol. Infect. Dis. 46:253-257.
4. Diekema, D. J., B. Petroelje, S. A. Messer, R. J. Hollis, and M. A. Pfaller. 2005. Activities of available and investigational antifungal agents against Rhodotorula species. J. Clin. Microbiol. 43:476-478.
5. Dube, M. P., P. N. R. Heseltine, M. G. Rinaldi, S. Evans, and B. Zawacki. 1994. Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit. Clin. Infect. Dis. 18:77-82.
6. Hajjeh, R. A., A. N. Sofair, L. H. Harrison, G. M. Lyon, B. A. Arthington-Skaggs, S. A. Mirza, M. Phelan, J. Morgan, W. Lee-Yang, M. A. Ciblak, L. E. Benjamin, L. Thompson Sanza, S. Huie, S. F. Yeo, M. E. Brandt, and D. W. Warnock. 2004. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J. Clin. Microbiol. 42:1519-1527.
7. Hazen, K. C., E. J. Baron, A. L. Colombo, C. Girmenia, A. Sanchez-Sousa, A. del Palacio, C. de Bedout, D. L. Gibbs, and The Global Antifungal Surveillance Group. 2003. Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion. J. Clin. Microbiol. 41:5623-5632.
8. Kahlmeter, G., and D. F. J. Brown. 2002. Resistance surveillance studies-comparability of results and quality assurance of methods. J. Antimicrob. Chemother. 50:775-777.
9. Livermore, D. M., E. J. Threlfall, M. H. Reacher, A. P. Johnson, D. James, T. Cheasty, A. Shah, F. Warburton, A. V. Swan, J. Skinner, A. Grahm, and D. C. E. Speller. 2000. Are routine test data suitable for the surveillance of resistance? Resistance rates amongst Escherchia coli from blood and CSF from 1991-1997, as assessed by routine and centralized testing. J. Antimicrob. Chemother. 45:205-211.
10. Livermore, D. M., A. P. Macgowan, and M. C. J. Wale. 2005. Surveillance of antimicrobial resistance: centralized surveys to validate routine data offer a practical approach. Br. Med. J. 317:614-615.
11. Luzzati, R., G. Amalfitano, L. Lazzarini, F. Soldori, S. Bellino, M. Solbiatic, M. C. Danzi, S. Vento, G. Todeschini, C. Vivenza, and E. Concia. 2000. Nosocomial candidemia in non-neutrophenic patients at an Italian tertiary care hospital. Eur. J. Clin. Microbiol. Infect. Dis. 19:602-607.
12. Magee, J. T., M. L. Heginbothom, and B. W. Mason. 2005. Finding a strategy: the case for co-operative research on resistance epidemiology. J. Antimicrob. Chemother. 55:628-633.
13. Meis, J., M. Petrou, J. Bille, D. Ellis, D. Gibbs, and the Global Antifungal Surveillance Group. 2000. A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Diagn. Microbiol. Infect. Dis. 36:215-223.
14. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution testing of yeasts. Approved standard, 2nd ed. M27-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
15. National Committee for Clinical Laboratory Standards. 2004. Method for antifungal disk diffusion susceptibility testing of yeasts: approved guidance M44-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
16. Nguyen, M. H., J. E. Peacock, Jr., A. J. Morris, D. C. Tanner, M. L. Nguyen, D. R. Snydman, M. M. Wagener, M. G. Rinaldi, and V. L. Yu. 1996. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am. J. Med. 100:617-623.
17. Ostrosky-Zeichner, L., J. H. Rex, P. G. Pappas, R. J. Hamill, R. A. Larsen, H. W. Horowitz, W. G. Powderly, N. Hyslop, C. A. Kauffman, J. Cleary, J. E. Mangino, and J. Lee. 2003. Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrob. Agents Chemother. 47:3149-3154.
18. Pfaller, M. A., and D. J. Diekema. 2002. Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J. Clin. Microbiol. 40:3551-3557.
19. Pfaller, M. A., D. J. Diekema, S. A. Messer, L. Boyken, R. J. Hollis, R. N. Jones, and the International Fungal Surveillance Participant Group. 2003. In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J. Clin. Microbiol. 41:28-83.
20. Pfaller, M. A., D. J. Diekema, S. A. Messer, L. Boyken, and R. J. Hollis. 2003. Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. J. Clin. Microbiol. 41:1440-1446.
21. Pfaller, M. A., and D. J. Diekema. 2004. Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin. Microbiol. Infect. 10(Suppl. 1):11-23.
22. Pfaller, M. A., and D. J. Diekema. 2004. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J. Clin. Microbiol. 42:4419-4431.
23. Pfaller, M. A., S. A. Messer, L. Boyken, S. Tendolkar, R. J. Hollis, and D. J. Diekema. 2004. Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002. J. Clin. Microbiol. 42:3142-3146.
24. Pfaller, M. A., D. J. Diekema, S. A. Messer, L. Boyken, R. J. Hollis, and R. N. Jones. 2004. In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents. Diagn. Microbiol. Infect. Dis. 48:101-105.
25. Pfaller, M. A., S. A. Messer, L. Boyken, R. J. Hollis, C. Rice, S. Tendolkar, and D. J. Diekema. 2004. In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program. Diagn. Microbiol. Infect. Dis. 48:201-205.
26. Pfaller, M. A., K. C. Hazen, S. A. Messer, L. Boyken, S. Tendolkar, R. J. Hollis, and D. J. Diekema. 2004. Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS Global Antifungal Surveillance Program. J. Clin. Microbiol. 42:3607-3612.
27. Pfaller, M. A., S. A. Messer, L. Boyken, C. Rice, S. Tendolkar, R. J. Hollis, G. V. Doern, and D. J. Diekema. 2005. Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990-2004). J. Clin. Microbiol. 43:2163-2167.
28. Pfaller, M. A., L. Boyken, S. A. Messer, S. Tendolkar, R. J. Hollis, and D. J. Diekema. 2005. Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS Global Antifungal Surveillance Program. J. Clin. Microbiol. 43: 5208-5213.
29. Rees, J. R., R. W. Pinner, R. A. Hajjeh, M. R. Brandt, and A. L. Reingold. 1998. The epidemiological features of invasive mycotic infection in the San Francisco Bay Area, 1992-1993: results of a population-based laboratory active surveillance. Clin. Infect. Dis. 27:1138-1147.
30. Richet, H., P. Roux, C. Des Champs, Y. Esnault, A. Andremont and the French Candidemia Study Group. 2002. Candidemia in French hospitals: incidence rates and characteristics. Clin. Microbiol. Infect. 8:405-412.
31. Stelling, J. M., K. Travers, R. N. Jones, P. J. Turner, T. F. O'Brien, and S. B. Levy. 2005. Integrating Escherichia coli antimicrobiol susceptibility data from multiple surveillance programs. Emerg. Infect. Dis. 11:873-882.
32. Tenover, F. C., M. J. Mohammed, J. Stelling, T. O'Brien, and R. Williams. 2001. Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organizations' external quality assurance system for antimicrobial susceptibility testing. J. Clin. Microbiol. 39:241-250.
33. Tortorano, A. M., J. Peman, H. Bernhardt, L. Klingspor, C. C. Kibbler, O. Faure, E. Biraghi, E. Canton, K. Zimmerman, S. Seaton, R. Grillot, and the ECMM Working Group on Candidaemia. 2004. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur. J. Clin. Microbiol. Infect. Dis. 23:317-322.
34. Walsh, T. J., A. Groll, J. Hiemenz, R. Flemming, E. Roilides, and E. Anaissie. 2004. Infections due to emerging and uncommon medically important fungal pathogens. Clin. Microbiol. Infect. 10(Suppl. 1):48-66.